About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, April 30th, 2015

The QualityStocks
Daily Stock List

graphic
graphic

VGTel, Inc. (VGTL)

PennyStocks24 reported this month on VGTel, Inc. (VGTL), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2002, VGTel, Inc. operates as 360 Entertainment and Productions. The Company is a multi-platform enterprise providing products and support in the entertainment industry. It is centering on a strategy of growing and building business units through investments and acquisitions. VGTel has its headquarters in Montebello, New York.

VGTel primarily develops, finances, produces, and distributes 4K UHD movie and film content. These are secured on top of five strong platforms of key subsidiaries, affiliates, as well as strategic partnerships. Additionally, the Company provides UHD scanning and post-production services and support. VGTel is working to grow and expand its presence in a broad spectrum of entertainment and event oriented acquisitions and investments, which are complementary to its current business platform.

Regarding Digital 4K Film Solutions, movies will be scanned from 15/70mm film to an 8K digital format. They will subsequently be downscaled to 4K and distributed for UHD broadcast and theatrical distribution. 4K UHD is four times the resolution of "HD." VGTel indicates that 4K UHD will be the new standard for television/home viewing. Most of these titles were originally shot in 15/70MM and other ultra high resolution formats suitable for IMAX/Giant Screen theaters. They have been digitally scanned at 4K or higher resolution.

VGTel - 360 Entertainment & Productions recently announced that its wholly-owned subsidiary 4K film scanning studio, Motion Picture Scanning Services, Inc. (MPSS), upgraded its 4K scanning work flow. It is now providing 4K scanning services for films and programs that were originally shot on 16mm and 35mm film stock.

Through MPSS, VGTel is aggressively expanding and growing its 4K business interests in light of commitments made by entertainment industry executives during CES 2015 and the emergence of 4K as the next standard for television. This expansion of services is VGTel’s response to the fast pace of growth occurring in the UHD/4K market.

Last month, VGTel - 360 Entertainment & Productions announced that MPSS entered into a cooperation agreement with New York, New York film studio and post-production company Domicile NYC. Domicile will serve as MPSS' sales agent for the New York metropolitan area to promote and sell MPSS' film scanning services in association with the post-production services now offered by Domicile.

VGTel, Inc. (VGTL), closed Thursday's trading session at $0.0026, up 4.00%, on 9,118,921 volume with 72 trades. The average volume for the last 60 days is 5,520,829 and the stock's 52-week low/high is $0.002/$0.6399.

Terra Tech Corp. (TRTC)

SmallCapVoice and OTPicks reported on Terra Tech Corp. (TRTC), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Terra Tech Corp., via its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The Company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Terra Tech works closely with expert horticulturists, engineers, and plant scientists to develop and manufacture advanced proprietary products for the developing urban agricultural industry and individual hobbyists.
 
The Company operates in two distinct markets. One is Commercial Agriculture. The other is Retail Agriculture. Regarding Commercial, it works with customers to help design, develop, and manufacture cultivation systems that maximize space and decrease energy costs. It offers rooftop/vertical hydroponic and aeroponic systems to custom designed greenhouse management systems.

Concerning Retail, Terra Tech, through GrowOp Technology, designs and manufactures an advanced and affordable line of horticulture equipment. Terra Tech also focuses on medical cannabis cultivation technology. Its products consist of Commercial Hydroponic and Aeroponic Systems with 'ADS' Automated Dosing Systems; Digital Atmospheric Controllers: Lighting, Humidity, C02 and more, and Commercial Greenhouse Manufacturing.

Through its wholly-owned subsidiary Edible Garden, Terra Tech cultivates a premier brand of local and sustainably grown hydroponic produce. This produce sells through leading grocery stores throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania. Terra Tech also has its subsidiaries MediFarm, MediFarm I and MediFarm II. MediFarm, MediFarm I, and MediFarm II, have all received provisional certificates from the State of Nevada in each local jurisdiction where they applied for a Medical Marijuana Establishment license.

Terra Tech has launched and continues to develop IVXX branded cannabis products. The Company has a new brand of premier quality cannabis products called IVXX, which is a wholly-owned subsidiary of Terra Tech. It offers a choice of expertly crafted cannabis extracts in the form of waxes, shatters, and concentrates. IVXX produces medical cannabis extracted products sold to permitted medical cannabis dispensaries across California.

Today, Terra Tech provided an update on the continued development of IVXX branded cannabis products. It announced that its brand of premier quality cannabis products is now available in Van Nuys, California at The Kind Center. The Kind Center is one of Los Angeles’ most patient focused dispensaries. The Kind Center rigorously tests its products and only carries the highest quality medications for its patients.

Terra Tech Corp. (TRTC), closed Thursday's trading session at $0.19, up 2.15%, on 919,468 volume with 133 trades. The average volume for the last 60 days is 1,315,913 and the stock's 52-week low/high is $0.1505/$0.809.

Amarantus BioScience Holdings, Inc. (AMBS)

BUYINS.NET, Top Stock Picks, TopStockAnalysts, PricelessPennyStocks, and PennyStockRumoors.net reported on Amarantus BioScience Holdings, Inc. (AMBS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Amarantus BioScience Holdings, Inc. is a biotechnology company that focuses on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration, and apoptosis. It is developing certain biologics surrounding the intellectual property (IP) and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, and other human diseases. Amarantus has an exclusive global license to the Lymphocyte Proliferation test (LymPro Test®) for Alzheimer's disease. Amarantus is headquartered in San Francisco, California.

The Company has also licensed Eltoprazine, a Phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD. In addition, it owns the IP rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF). It is developing MANF-based products as treatments for brain disorders. Amarantus’ lead therapeutic program MANF is a targeted therapeutic to address the underlying Programmed Cell Death (Apoptosis) associated with a wide assortment of devastating human disorders.

Amarantus BioScience also owns IP for the diagnosis of Parkinson's disease (NuroPro) and the discovery of neurotrophic factors (PhenoGuard™). The Company is a Founding Member of the Coalition for Concussion Treatment (#C4CT). This movement began in association with Brewer Sports International (BSI). It is working to raise awareness of new treatments in development for concussions and nervous-system disorders.

Last month, Amarantus BioScience announced that it opened and now has an active Investigational New Drug (IND) application with the Neurology Division of the U.S. Food and Drug Administration (FDA) to commence a Phase 2b program of Eltoprazine for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). Amarantus expects to start patient enrollment and dosing in a 60-subject clinical study in individuals with Parkinson's disease (PD) in Q2 2015.

Yesterday, Amarantus BioScience announced that the European Commission, acting on the positive recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP), granted orphan drug status for MANF (mesencephalic-astrocyte-derived neurotrophic factor) for the treatment of retinitis pigmentosa (RP). RP refers to a group of inherited diseases causing retinal degeneration often leading to blindness. Amarantus earlier announced in December 2014 that it also received orphan drug designation for MANF for the treatment of RP from the FDA.

Amarantus BioScience Holdings, Inc. (AMBS), closed Thursday's trading session at $0.0469, up 1.96%, on 2,235,483 volume with 160 trades. The average volume for the last 60 days is 4,804,323 and the stock's 52-week low/high is $0.0325/$0.196.

Enertopia Corp. (ENRT)

PennyStocks24, Penny Champions, Penny Dreamers, Penny Stock General, and MassiveStockProfits reported earlier on Enertopia Corp. (ENRT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Enertopia Corp. is centering on the growing Canadian Medical Marijuana business opportunity. Currently, it owns an interest in two separate medical marihuana grow facilities located in Canada. Enertopia is focusing on the production, cultivation, and distribution of Medical Marihuana (MMJ) under the new Canadian Federal Government Marihuana for Medical Purposes Regulations (MMPR) Program. Enertopia is based in Vancouver, British Columbia.

Enertopia signed a Joint Venture (JV) Agreement with the World of Marihuana Productions Ltd. formerly known as 0984321 B.C. Ltd. under the Letter of Intent (LOI) dated November 4, 2013. The Company paid $100,000 USD and issued 5,000,000 shares of common stock on signing the (JV) Agreement. It can earn up to a 51 percent net revenue interest (NRI) in the JV. 

Lexaria Corp. reported in March 2014 that its Board decided to make a strategic entry into the medical marihuana business via an important Joint Venture with Enertopia. Mr. Robert McAllister, Chief Executive Officer and Chair of Enertopia, agreed to join the Advisory Board of Lexaria to evaluate and negotiate marihuana acquisitions and joint ventures (JVs).

Enertopia is engaged in the Lexaria JV in Burlington, Ontario. This facility consists initially of roughly 30,000 sq.ft., with a right of first refusal having been acquired for another 45,000 sq. ft. totaling 75,000 sq. ft. to accommodate future growth.

Enertopia announced the signing of a JV agreement, in February 2014, to acquire up to 75 percent of the Regina, Saskatchewan based scalable, Green Canvas MMJ growing facility. The Green Canvas facility is scalable to 55,000 sq. ft. presently undergoing upgrades to make 14,000 sq. ft. production space compliant with MMPR standards.

Enertopia earlier announced that Health Canada advised the Company that the Burlington, Ontario application has advanced to the Enhanced Screening Stage of the application process. Enertopia’s license application with JV partner Lexaria Corp. (LXRP), submitted for licensed producer in July 2014, is now at the Enhanced Screening process. The Burlington JV has applied to produce 10,000kg of Medical Marihuana annually under its Licensed Producer application.

Enertopia announced its move into the health and wellness industry with the launch of its V-Love™ product at the Vancouver Wellness Show on February 13-15, 2015. V-Love™ does not contain any cannabinoids, as they are illegal in Canada. However, Enertopia plans to launch CBD-infused products in jurisdictions where they are legalized in the future. V-Love™ is a sexual gel for women.

Today, Enertopia announced that V-Love™ has been placed on the store shelves and is now available for purchase in Canada. V-Love™ is now available for purchase at the Loblaws City Market, 1650 Lonsdale Avenue, North Vancouver, British Columbia. Mr. Robert McAllister, Company President, said "We are excited to have V-Love™ available for retail sale for our customers."

Enertopia Corp. (ENRT), closed Thursday's trading session at $0.044, up 62.96%, on 744,918 volume with 72 trades. The average volume for the last 60 days is 234,303 and the stock's 52-week low/high is $0.023/$0.28.

Novation Companies, Inc. (NOVC)

Wall Street Resources, Zacks, and RedChip reported previously on Novation Companies, Inc. (NOVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Novation Companies, Inc. owns and operates early-stage businesses in the technology-enabled services industry. Its commitment is to bringing the best product or service in its sector to the marketplace.  Currently, Novation owns, wholly or in the majority, interests in CorvisaCloud and Corvisa Services. Novation has its corporate headquarters in Kansas City, Missouri.

Novation acquired CorvisaCloud in 2012. It was originally named IVR Central LLC. Novation rebranded the business to CorvisaCloud in 2013. Novation Companies owns 100 percent of CorvisaCloud. CorvisaCloud is a developer and seller of proprietary, cloud-based contact center software and private branch exchange (PBX) systems. In addition, CorvisaCloud provides implementation consulting services for its own clients and clients of a leading customer relationship management (CRM) software provider.

CorvisaCloud is a provider of cloud-based, proprietary communication software under the brand CorvisaOne. CorvisaOne is a full contact center suite including inbound and outbound contact center functionality and full private branch exchange (PBX) phone system functionality. Features of the communications software include interactive voice response, automated call distribution, campaign dialing, and a variety of other services. All of these are delivered to clients as part of a complete, fully-hosted cloud solution.

The software is fully integrated with the leading CRM provider and can be integrated with other third party software solutions through the Company’s advanced web service, JavaScript and platform integration solutions. Corvisa Services offers software development and Novation shared services. Services include Salesforce® Implementation Services. CorvisaCloud's Salesforce implementation services help a business get up and running quickly to deliver better experiences for its customers and make life easier for its employees.

Novation also offers Workflow Consulting Services. CorvisaCloud's end-to-end workflow consulting and professional services assist in turning a business’s initiatives into reality. It does so while minimizing the pressure on a business’s employees. Corvisa has a strategic alliance with leading connectivity partner and telecommunications master agency, PlanetOne Communications. The new relationship will play a vital role in Corvisa’s Channel Partner Program and expanded go-to-market strategy.

Last week, Novation Companies announced that it entered into an agreement with Lone Star Value Management, LLC and its affiliates. Novation agreed to expand the size of its Board of Directors from six to eight directors and to appoint Mr. Jeffrey E. Eberwein and Mr. Robert G. Pearse, effective immediately, to fill the vacancies on the Board as independent directors.

Mr. Lance Anderson, Novation Chairman/ CEO, said, "We welcome Jeff and Bob to the Board and look forward to their contributions. Bob's experience as an operator in the technology industry and Jeff's investment experience, in both technology-related businesses and companies with large NOLs, will be helpful to the business as we continue to work to enhance shareholder value."

Novation Companies, Inc. (NOVC), closed Thursday's trading session at $0.385, up 2.67%, on 84,620 volume with 24 trades. The average volume for the last 60 days is 44,225 and the stock's 52-week low/high is $0.192/$0.40.

Spiral Toys, Inc. (STOY)

PREPUMP STOCKS, Penny Stock Newsletter, Penny Picks, Damn Good Penny Picks, SmallCapFinancialWire, HoleinOneStocks.net, Jet-Life Penny Stocks, Equity Observer, Michael Stone, Growing Stocks Reports, and Research Driven Investor reported this month on Spiral Toys, Inc. (STOY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spiral Toys, Inc. is a mobile-connected wireless technology company based in Los Angeles, California. The Company’s commitment is to develop, market, and sell products and mobile applications in the mobile-connected space. Spiral Toys has developed several technology platforms that enable it to acquire and engage customers with consumer products and toys. The Company sells its products around the world.

Spiral Toys collects revenue on the physical purchase of goods, and the sale of digital content by way of the Apple APP Store and Google Marketplace. It has developed an integrated hardware/software/cloud solution, which enables mobile-connected entertainment. Its mobile-connected entertainment platform connects physical items to today's top mobile devices via BTLE, NFC, ultrasonics, and other technologies, creating a unique interactive user experience.

Spiral Toys is developing additional applications based on its platform technology for many different verticals within the entertainment industry. In addition, the Company acts as co-developer with major entertainment studios.

Spiral Toys has a partnership with global toy distributor Jay@Play and On Demand Global to launch its interactive plush toy line, CloudPets™, on Direct Response Television. This was launched on March 1, 2015. CloudPets™ will additionally be released into mass retail stores throughout the nation in August 2015. CloudPets™ is the latest iteration of Spiral Toys' proprietary interactive technology platform that connects children's plush toys to today's top mobile devices through wireless technology.

CloudPets™ enables one to send a message to anyone, from anywhere, and have that message delivered through a teddy bear. Spiral Toys’ technology allows CloudPets™ to send and receive messages through mobile devices, powers the CloudPets™ mobile apps, and enables the addition of features in the future to make CloudPets™ do more.

Spiral Toys also has a partnership with C&C RFID. The partnership will center on the research and development of new ways to use NFC technology in Spiral Toys’ products, and the manufacturing of NFC chips for Spiral's upcoming line of wireless-enabled stickers. C&C RFID is a near field communication (NFC) manufacturer (a subsidiary of C&C Joint Printing Co).

This week, Spiral Toys announced an initial purchase order of 500,000 units of its flagship CloudPets™ toy line from partner Jay@Play. Jay@Play is an established international distributor servicing retailors including Walmart, Target, TRU, Kmart and Bed Bath and Beyond.

Spiral Toys President/ CEO, Mr. Mark Meyers, said, "The initial release of 500,000 units to North America's preeminent retailers is an enormous accomplishment for CloudPets, and is an excellent indicator of the strength of our strategic plan."

Spiral Toys, Inc. (STOY), closed Thursday's trading session at $0.5745, up 0.79%, on 91,566 volume with 62 trades. The average volume for the last 60 days is 83,259 and the stock's 52-week low/high is $0.20/$0.8743.

DigitalTown, Inc. (DGTW)

TopPennyStockMovers and Real Pennies reported on DigitalTown, Inc. (DGTW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DigitalTown, Inc. is a domain management company, a Google Apps Authorized Reseller, and a cloud services broker. The Company engages in Domain Leasing and also has its DigitalTown Software Group, as well as its Domain Name Marketplace. The Company has its head office in Burnsville, Minnesota. DigitalTown’s shares trade on the OTC Markets Group’s OTCQB.

Regarding the DigitalTown Domain Portfolio for leasing, its features include easy online payments, DNS online management, and secure third party escrow accounts. In addition, DigitalTown Software Group provides a portfolio of greater than 20,000 school-related domains for lease by athletic directors, schools, teams, alumni, and communities. These branded domains, in total, are relevant to over 1 million community’s organizations, 700,000 teams, across 27,000 high schools.

DigitalTown has partnered with the NIAAA (National Interscholastic Athletic Administrators Association) and Epik.com, an ICANN accredited registrar. Together, the Company, NIAAA, and Epik.com are working on solutions to increase the visibility of interscholastic athletics via the Internet.

The NIAAA preserves, enhances, and promotes the educational values of interscholastic athletics via the professional development of its members in the areas of education, leadership, and service. Epik combines first-rate integrated domain name management, registry, development services, and also an active domain marketplace.

Recently, DigitalTown announced that it partnered with ScoreStream, Inc. of San Diego, California, to provide live scores across its 20,000 plus community/high school domain portfolio. The ScoreStream app has more than 25,000 high schools and 20,000 additional teams at the club, recreational, as well as semi-pro level. The ScoreStream app is built for Android and Apple IOS.

DigitalTown has started the roll-out of its national and local sponsor programs, which was announced in January of this year. The Company is bringing data that connects the local businesses looking to sponsor and build brands locally and advertise at the same time as live community events and national accounts at the local level on a single platform.

DigitalTown, Inc. (DGTW), closed Thursday's trading session at $0.25, even for the day. The average volume for the last 60 days is 5,128 and the stock's 52-week low/high is $0.10/$0.99.

graphic

The QualityStocks
Company Corner

graphic
graphic

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.25, up 38.89%, on 3,258 volume with 2 trades. The stock’s average daily volume over the past 60 days is 1,507 and its 52-week low/high is $0.06/$0.45.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview

Dominovas Energy Corp. Appoints International Business Professional to Board of Directors

Dominovas Energy and Delphi Sign MOU

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.004, up 33.33%, on 824,775 volume with 25 trades. The stock’s average daily volume over the past 60 days is 1,181,881, and its 52-week low/high is $0.0022/$0.2789.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

Save The World Air, Inc. (ZERO)

The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.45275, up 7.80%, on 116,759 volume with 37 trades. The stock’s average daily volume over the past 60 days is 113,874, and its 52-week low/high is $0.3401/$0.86.

Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.

In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.

The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.

STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.

Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer

Save The World Air, Inc. Company Blog

Save The World Air, Inc. News:

STWA Selected as a Finalist for the 2015 Global Petroleum Show Awards

STWA Reports 2014 Year-End Financial Results and Provides Operational Update

STWA Sets Date for Its Year-End 2014 Earnings Results Release and Conference Call

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.0749, up 15.77%, on 1,825 volume with 1 trade. The stock’s average daily volume over the past 60 days is 85,897, and its 52-week low/high is $0.0423/$0.22.

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling Groups Blended Schools Network Powers Mountain House High Schools Personalized Learning; BSN Curriculum Achieves California A-G Certification

Sibling Group's Urban Planet Mobile Deepens Strategic Partnership With Imagine Easy Solutions and EasyBib; UPMs Writing Planet Essay Scoring Solution to Be Offered Across All Imagine Easy Citation Websites Worldwide

Strategic Partner Shenzhen Times Increases Stake in Sibling Group; $5,500,000 Warrant Exercise to Fund Growth Initiatives

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0032, up 6.67%, on 819,800 volume with 14 trades. The stock’s average daily volume over the past 60 days is 4,378,371, and its 52-week low/high is $0.0008/$0.09.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

One World Holdings Announces Yearly Revenue Increase of 532%

One World Holdings Raises Capital to Fund National Expansion and Convertible Note Elimination

The One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.058, up 1.75%, on 24,850 volume with 3 trades. The stock’s average daily volume over the past 60 days is 10,033, and its 52-week low/high is $0.032/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $8.10, off by 19.00%, on 1,300 volume with 3 trades. The stock’s average daily volume over the past 60 days is 638, and its 52-week low/high is $3.16/$15.00.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder

Dr. Gerard Sanacora Joins VistaGen's Clinical and Scientific Advisory Board

VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

The Stock Psycho
(GRNBF)

2.

PennyPickAlerts
(DCNPF)

3.

QualityStocks
(DNRG)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251